Compare Amgen, Inc. (AMGN) vs Quanta Services Inc (PWR) Price & Performance
Price performance
Price movement over the last 24 hours
Key statistics
Key statistics
Amgen, Inc. vs Quanta Services Inc — how do they compare? Amgen, Inc. trades at $363.66 (market cap $196.12B), while Quanta Services Inc trades at $647.43 (market cap $98.82B). The key difference: Amgen, Inc. is the larger of the two by market cap, and Amgen, Inc. pays the higher dividend (2.77%). Which is the better fit depends on your goals.
| AMGN | PWR | |
|---|---|---|
Market Cap | $196.12B | $98.82B |
Sector | Health | Industrials |
52-Week High | $388.16 | $785.24 |
52-Week Low | $271.18 | $372.50 |
Enterprise Value | $241.41B | $104.78B |
Dividend Yield | 2.77% | 0.07% |
Aura AI Summary
Signals from Pluang's Aura AI — not financial advice
Aura AI Summary
Signals from Pluang's Aura AI — not financial advice
AMGN trades at $363.39, down slightly by 0.06% today, with a bullish technical signal from moving averages. The company reported strong Q1 2026 earnings, beating estimates with EPS of $5.15 versus $4.77 expected. Revenue grew to $36.75B in 2025, with a net income margin of 20.96%. Recent news includes a favorable court ruling blocking a price cap on Enbrel in Colorado, but regulatory challenges persist for Tavneos in Europe.
The outlook remains positive due to consistent earnings beats and a diversified product portfolio, though risks include regulatory setbacks and competitive pressures. Analyst consensus is bullish with a 57.9% buy rating and a price target of $357.38, slightly below the current price, indicating potential for stability with upside from pipeline developments.
Quanta Services (PWR) trades at $658.56, down 1.44% with a bearish technical signal despite strong fundamental performance. The company has consistently beaten earnings estimates for three consecutive quarters, with Q2 2026 results pending. Revenue growth has been robust, increasing from $17.1B in 2022 to $28.5B in 2025, though profit margins remain modest at 3.67%. Analyst sentiment remains overwhelmingly positive with 27 buy ratings and a consensus price target of $836.80, representing 27% upside potential.
PWR presents a compelling growth story driven by infrastructure spending and AI-related opportunities, with management projecting technology revenues to rise over 110% by 2030. However, the stock trades at premium valuations (P/E 90.34) and faces execution risks from aggressive capital expenditure plans. The bearish technical setup suggests near-term pressure, but strong institutional support and massive infrastructure backlog provide long-term catalysts.
Returns comparison
Trailing returns across standard periods
Returns comparison
Trailing returns across standard periods
Top news
Latest headlines on both assets
Top news
Latest headlines on both assets
About Amgen, Inc.
Amgen is a leader in biotechnology-based human therapeutics, with historical expertise in renal disease and cancer supportive-care products. Flagship drugs include red blood cell boosters Epogen and Aranesp, immune system boosters Neupogen and Neulasta, and Enbrel and Otezla for inflammatory diseases. Amgen introduced its first cancer therapeutic, Vectibix, in 2006 and markets bone-strengthening drug Prolia/Xgeva (approved 2010) and Evenity (2019). The acquisition of Onyx bolstered the firm's therapeutic oncology portfolio with Kyprolis. Recent launches include Repatha (cholesterol-lowering), Aimovig (migraine), Lumakras (lung cancer), and Tezspire (asthma). Amgen's biosimilar portfolio includes Mvasi (biosimilar Avastin), Kanjinti (biosimilar Herceptin), and Amgevita (biosimilar Humira).
Read more on AMGN →About Quanta Services Inc
Quanta Services is a leading provider of specialty contracting services, delivering comprehensive infrastructure solutions for the electric and gas utility, communications, pipeline, and energy industries in the United States, Canada, and Australia. Quanta reports its results under two reportable segments: electric power infrastructure solutions and underground utility and infrastructure solutions. In October 2021, the company completed the acquisition of Blattner, a provider of comprehensive engineering, procurement, and construction solutions to customers in the renewable energy industry.
Read more on PWR →
